FDA names drugmakers accused of blocking cheaper generics
TRENTON, N.J. (AP) — U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.
The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, some carrying six-figure annual price tags, who are under scrutiny. The agency also lists how many inquiries it has received from generic drugmakers who say they are having trouble getting access to the brand-name drugs.
Generic drug companies generally require 1,000 to 1,500 units, such as pills, of... read more
- 11:57 Sutherland Springs survivor urges gun owners to push back against NRA
- 11:18 The Latest: US team heading to Singapore to work on summit
- 10:19 Family grateful for Utah man's 'miracle' Venezuela release
- 09:36 Resistance makes subtle impact even where Trump is popular
- 02:03 Giuliani says White House wants briefing on classified info
- 01:02 Trump stays out of messy House immigration fight
- 00:46 Trump shifts stance on Korea summit from 'off' to 'maybe'
- 00:46 Trump's dizzying shifts on issues from NK, guns, health care